Chen Yu-Hsuan, Tu Yu-Ling, Chen Han-Ku, Shih Shen-Liang
Department of General Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, No.100, Tzyou 1st Rd., Sanmin Dist., Kaohsiung City 80756, Taiwan.
Department of Pathology, Yuan's General Hospital, No.162 Cheng Kung 1st Road, Kaohsiung City 80249, Taiwan.
Int J Surg Case Rep. 2022 Feb;91:106804. doi: 10.1016/j.ijscr.2022.106804. Epub 2022 Feb 2.
Phyllodes tumors (PT) account for approximately 1% of all breast tumors. The coexistence of phyllodes tumor and invasive lobular carcinoma in the ipsilateral breast is extremely rare with fewer than six cases reported worldwide in the last 20 years. We hereby present the first in Taiwan.
A 43-year-old female was presented with a protruding tumor with bleeding tendency over left breast in 2016. Breast sonography revealed highly suspected malignancy (ACR BI-RADS category 5). Computed tomography scan disclosed a protruding mass occupying the left breast. Core needle biopsy showed a fibroepithelial lesion favoring fibroadenoma. Considering clinicopathological discrepancy, a nipple-sparing mastectomy was conducted. Pathology report revealed a benign PT with an incidental finding of invasive lobular carcinoma (pT1cN0) within the tumor. Due to tumor recurrence, the patient received re-operation of total mastectomy in 2017, and is under regular adjuvant hormonal therapy without cancer recurrence to date.
Physicians could easily overlook carcinomas enclosed by PTs due to its occult property. However, when carcinomatous changes arise from within or along with the PT, the proposed therapeutical course may be altered. Moreover, invasive carcinoma components in PTs possess potential for lymph node metastasis. Multidisciplinary cooperation is key in detecting and managing PT with synchronous carcinomatosis.
Thorough examination of the excised tumor specimen and ensuring an adequate surgical margin is necessary. Sentinel lymph node biopsy (SLNB) should be considered whenever suspicious clinical features occur in PT patients. This may aid in the detection of microscopic invasive carcinomatous change.
叶状肿瘤(PT)约占所有乳腺肿瘤的1%。同侧乳腺中叶状肿瘤与浸润性小叶癌并存极为罕见,过去20年全球报告的病例少于6例。在此,我们报告台湾首例此类病例。
一名43岁女性于2016年因左乳出现有出血倾向的突出肿瘤前来就诊。乳腺超声检查显示高度怀疑为恶性(美国放射学会乳腺影像报告和数据系统[ACR BI-RADS] 5类)。计算机断层扫描显示左乳有一突出肿块。粗针活检显示为倾向于纤维腺瘤的纤维上皮性病变。考虑到临床病理差异,实施了保乳根治术。病理报告显示为良性叶状肿瘤,肿瘤内偶然发现浸润性小叶癌(pT1cN0)。由于肿瘤复发,患者于2017年接受了全乳切除再次手术,目前正在接受常规辅助激素治疗,至今未出现癌症复发。
由于其隐匿性,医生很容易忽略被叶状肿瘤包裹的癌症。然而,当癌性改变在叶状肿瘤内部或与之同时出现时,建议的治疗方案可能会改变。此外,叶状肿瘤中的浸润性癌成分具有淋巴结转移的可能性。多学科合作是检测和管理合并同步癌变的叶状肿瘤的关键。
对切除的肿瘤标本进行全面检查并确保足够的手术切缘是必要的。当叶状肿瘤患者出现可疑临床特征时,应考虑进行前哨淋巴结活检(SLNB)。这可能有助于检测微小浸润性癌性改变。